U.S. Emerging Melanoma Therapeutics Markets Immunotherapeutics Lead Research and Development Efforts

1
U.S. Emerging Melanoma Therapeutics
MarketsImmunotherapeutics Lead Research and
Development Efforts

• The trend toward immunotherapeutics will play an
  important role in the future markets for melanoma
  treatments.

Pharmaceuticals Analyst Team Frost Sullivan
2
Key Features

• Detailed insights into recent developments and
  trends
• Drivers, restraints, challenges, and strategic
  recommendations
• Analyst insights into hot topics and emerging
  
• applications in the melanoma therapeutics
  market
• Market-sizing and competitive analysis
• Market forecasts and opportunity analyses
• Quarterly assessments
• End-user analysis

3
What We Offer

• Coverage The United States
• Proven methodology using extensive primary and
  secondary data as well as research
• Focused information and strategies that cover
  business and technology issues
• Credible data and analyses that highlight
  industry dynamics
• Precise strategies to help you create winning
  business plans

4
Who Will Benefit?

• Current Market Participants
• Find out how you compare with the competition
• Assess current and future drivers as well as
  restraints
• Determine and exploit new market share
  opportunities
• New Entrants
• Analyze the associated challenges
• Calculate timescales for strategy implementation
• Position yourself to capitalize on the unmet
  needs of the market
• Investment Community
• Analyze long-term strategies of companies
• Determine participants that will outperform the
  competition
• Assess the attractiveness of investing in the
  market

5
Key Market Participants
Antigenics AVAX Technologies, Inc. Bayer AG Bayer
Pharmaceuticals, Inc. Bristol-Myers Squibb,
Inc. CancerVax Corp. Celgene Corp. Chiron
Corp. Corixa Cytran, Inc. EntreMed, Inc. Enzon,
Inc. Genta, Inc. Genzyme Molecular Oncology
ImClone Systems, Inc. Immunex Corp. Maxim
Pharmaceuticals MGI Pharma, Inc. Progenics
Pharmaceuticals, Inc. Protarga,
Inc. Schering-Plough Shire Pharmaceutical Group
plc SuperGen Therion Biologics Corp. Titan
Pharmaceuticals, Inc. Tularik, Inc. Valentis,
Inc. Vical, Inc.
6
For More Information

• Call toll free 877 GO FROST
• (877.463.7876)
• Fax toll free 888.690.3329
• E-mail myfrost_at_frost.com
• Visit www.frost.com